News >

Marshall Reflects on Major Advances in mCRC

Caroline Seymour
Published: Wednesday, Apr 01, 2020

John L. Marshall, MD

John L. Marshall, MD
The treatment of patients with metastatic colorectal cancer (mCRC) should be approached with more fluidity than rigidity, said John L. Marshall, MD, who added that the use of upfront and potentially repeat molecular testing can help optimize such an approach.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication